Design and synthesis of dual ALK/BRD4 inhibitors

被引：0
|
作者：
Watts, Ellen [1 ]
Tucker, Elizabeth [2 ]
Heidenreich, David [3 ]
Bellenie, Benjamin [1 ]
Knapp, Stefan [3 ,4 ]
Chesler, Louis [2 ]
Hoelder, Swen [1 ]
机构：
[1] Inst Canc Res, Div Canc Therapeut, London, England
[2] Inst Canc Res, Paediat Solid Tumour Biol & Therapeut Team, London, England
[3] Goethe Univ Frankfurt, Frankfurt, Germany
[4] Struct Genom Consortium, Oxford, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
63
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Design and synthesis of a dual kinase-bromodomain inhibitor targeting ALK and BRD4
    Watts, Ellen
    Heidenreich, David
    Tucker, Elizabeth
    Bellenie, Benjamin
    Knapp, Stefan
    Chesler, Louis
    Hoelder, Swen
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [2] Synthesis and evaluation of novel dual BRD4/HDAC inhibitors
    Amemiya, Seika
    Yamaguchi, Takao
    Hashimoto, Yuichi
    Noguchi-Yachide, Tomomi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (14) : 3677 - 3684
  • [3] Design and Synthesis of Dual EZH2/BRD4 Inhibitors to Target Solid Tumors
    Guo, Zhirong
    Sun, Yameng
    Liang, Liyun
    Lu, Wenhua
    Luo, Bingling
    Wu, Zhouming
    Huo, Bitao
    Hu, Yumin
    Huang, Peng
    Wu, Qiang
    Wen, Shijun
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (09) : 6573 - 6592
  • [4] Design, synthesis and biological evaluation of dihydroquinoxalinone derivatives as BRD4 inhibitors
    Yang, Yifei
    Zhao, Leilei
    Xu, Bin
    Yang, LingYun
    Zhang, Jian
    Zhang, Huibin
    Zhou, Jinpei
    [J]. BIOORGANIC CHEMISTRY, 2016, 68 : 236 - 244
  • [5] Dual HDAC/BRD4 inhibitors against cancer
    Negar Omidkhah
    Farzin Hadizadeh
    Razieh Ghodsi
    [J]. Medicinal Chemistry Research, 2021, 30 : 1822 - 1836
  • [6] Dual HDAC/BRD4 inhibitors against cancer
    Omidkhah, Negar
    Hadizadeh, Farzin
    Ghodsi, Razieh
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (10) : 1822 - 1836
  • [7] Design, synthesis and mechanism studies of dual EZH2/BRD4 inhibitors for cancer therapy
    Chen, Xinye
    Wang, Cheng
    Lu, Dehua
    Luo, Heng
    Li, Shang
    Yin, Fucheng
    Luo, Zhongwen
    Cui, Ningjie
    Kong, Lingyi
    Wang, Xiaobing
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 91
  • [8] Design and synthesis of dual BRD4/Src inhibitors for treatment of triple-negative breast cancer
    Wang, Ying
    Huang, Aima
    Chen, Lu
    Sun, Fan
    Zhao, Man
    Zhang, Ming
    Xie, Yubao
    Xu, Shiyu
    Li, Min
    Hong, Liang
    Li, Guofeng
    Wang, Rui
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
  • [9] Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity
    Watts, Ellen
    Heidenreich, David
    Tucker, Elizabeth
    Raab, Monika
    Strebhardt, Klaus
    Chesler, Louis
    Knapp, Stefan
    Bellenie, Benjamin
    Hoelder, Swen
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (05) : 2618 - 2637
  • [10] Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors
    Xu, Kai-Yan
    Wang, Xue-Ting
    Cheng, Lei
    Cui, Qi-Hang
    Shi, Jian-Tao
    Zhang, Li-Wen
    Chen, Shi-Wu
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 78
12345